TORL

TORL BioTherapeutics

This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

Oxford BioTherapeutics

Oxford BioTherapeutics develops targeted antibody-drug conjugates and immuno-oncology therapies for patients with advanced solid tumours through its proprietary proteomic database.

Valink Therapeutics

Valink Therapeutics develops next-generation bispecific antibody-drug conjugates to treat solid tumours for cancer patients.

Emergence Therapeutics

This biopharmaceutical company develops antibody-drug conjugate immunotherapies to treat solid tumours for patients with high unmet medical needs.

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.